Security key
92025Y103
Valneva SE - Ordinary Shares, nominal value EURO0.15 per share, represented by American Depository Shares (VALN)
CUSIP: 92025Y103
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Ordinary Shares, nominal value EURO0.15 per share, represented by American Depository Shares
- Total 13F shares
- 5,196,705
- Total 13F value
- $45,834,921
- Share change
- -76,900
- SEC-reported price per share
- $8.82
- Number of holders
- 19
- Value change
- -$814,852
- Number of buys
- 8
- Number of sells
- 9
- Shares outstanding
- 191,097,667
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
19
Top holders
10
VALN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Valneva SE SEC filings
Valneva SE company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92025Y103
Recent filing periods:
Ownership snapshot
Top reported holders of VALN - Valneva SE - Ordinary Shares, nominal value EURO0.15 per share, represented by American Depository Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Novo Holdings A/S
Disclosed value leader
Novo Holdings A/S
Comparable rows
15/15
Latest evidence
30 Sep 2025
13F
Lead comparable stake: 1.2%
Showing 1-6 of 15 holder rows.
Quick read
Novo Holdings A/S leads the comparable SEC ownership view at 1.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Novo Holdings A/S's linked filing trail.
Comparable ownership
Top 5
Novo Holdings A/S
1.2%
Frazier Life Sciences Management,...
1.2%
GENERAL AMERICAN INVESTORS CO INC
0.19%
WELLS FARGO & COMPANY/MN
0.08%
MORGAN STANLEY
0.02%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Novo Holdings A/S |
13F
Company
|
1.2%
|
$28,609,000
2,345,000 shares
|
— | 30 Sep 2025 |
| Frazier Life Sciences Management, L.P. |
13F
Company
|
1.2%
|
$27,958,325
2,291,666 shares
|
— | 30 Sep 2025 |
| GENERAL AMERICAN INVESTORS CO INC |
13F
Company
|
0.19%
|
$4,323,204
354,361 shares
|
— | 30 Sep 2025 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
0.08%
|
$1,878,678
153,990 shares
|
— | 30 Sep 2025 |
| MORGAN STANLEY |
13F
Company
|
0.02%
|
$402,442
32,987 shares
|
— | 30 Sep 2025 |
| MARSHALL WACE, LLP |
13F
Company
|
0.02%
|
$380,776
31,211 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
5,196,705
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
18
Q4 2025 holders
19
Holder diff
1
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend